Comparative Effectiveness of endoscopic assessment of GER and BE

描述（申请人提供）：巴雷特食管（BE）是众所周知的GER并发症，是已知最强的食管腺癌（EAC）前体。因此，确定有效的筛选方法，早期发现BE是非常需要的。目前BE筛查的障碍包括：1)无法在人群中有效地利用镇静内窥镜检查（sEGD）； 2)目前基于ger的BE检测范式。转诊中心的研究表明，非镇静经鼻内窥镜检查（uTNE）和sEGD的准确性相当。然而，在一般人群中，uTNE的患者可接受性和诊断率仍然未知。我们小组的初步研究已经确定了BE筛查的显著水平，并证明了在特定人群中使用uTNE和sEGD的初步可行性。我们建议检验中心假设，即uTNE在be人群筛查中的相对有效性将大于sEGD，具体目的如下：具体目的1：评估人群队列中uTNE和sEGD筛查be的参与情况。目的1a：比较BE筛查与uTNE和sEGD的参与率。我们将从一个确定的人群队列中随机抽取三个年龄（50岁至50岁）、性别和反流症状分层队列（每个队列150名受试者）。每个受试者将被随机分配到sEGD（队列1），或医院内的uTNE（队列2），或移动医疗面包车内的uTNE（队列3）。子目标1b：评估参与BE人群筛查的预测因素。将收集和分析先验的人口统计学和临床因素，以确定参与筛查的预测因素。具体目标2：在人群队列中前瞻性地比较uTNE和sEGD的临床疗效。Subaim 2a：比较sEGD、huTNE和muTNE队列的食管评估质量。质量标准将包括1)成功的食管插管，2)完整的食管评估，3)成功的活检采集，4)通过视频评估进行独立的质量评分。目的2b：使用一份经过验证的症状问卷，比较按有无GER症状分层的队列之间食管损伤（食管炎、狭窄和BE）的检出率。具体目标3：在以人群为基础的队列中，前瞻性地比较短期资源利用率和患者对使用sEGD、huTNE和muTNE进行筛查的偏好。子目标3a：在三个测试策略队列中使用经过验证的工具来测量短期患者报告的缺点（与每种测试策略相关的患者偏好）。子目标3b：比较总短期成本（直接和间接）以及按与每个测试策略相关的服务类型分配的成本。这项研究的重要意义在于需要确定有效的以社区为基础的BE筛查策略，这有可能改善EAC患者的预后。

DESCRIPTION (provided by applicant): Barrett's esophagus (BE), a well-known complication of GER, is the strongest known precursor of esophageal adenocarcinoma (EAC). Thus, identifying effective screening approaches for the early detection of BE are highly desired. Current impediments to BE screening include 1) the inability to utilize sedated endoscopy (sEGD) effectively in populations and 2) current GER-based paradigms for detecting BE. Referral center studies demonstrate comparable accuracy between unsedated transnasal endoscopy (uTNE) and sEGD. However, patient acceptability and diagnostic yield with uTNE in general populations remain unknown. Preliminary Studies from our group have identified a significant level of interest for BE screening, and demonstrated initial feasibility of using uTNE and sEGD within a defined population. We propose to test the Central Hypothesis that the comparative effectiveness of uTNE will be greater than sEGD in population screening for BE with the following specific aims: Specific Aim 1: To assess participation in screening for BE with uTNE and sEGD in a population cohort. Subaim 1a: To compare participation rates for BE screening with uTNE and sEGD. We will randomly sample three age (> 50 years), gender and reflux symptom stratified cohorts (150 subjects each) from a defined population cohort. Each subject will be randomized to either sEGD (cohort 1), or uTNE in the hospital (huTNE, cohort 2), or uTNE within a mobile health care van (muTNE, cohort 3). Subaim 1b: To assess predictors of participation in population screening of BE. A priori demographic and clinical factors will be collected and analyzed to identify predictors of participation in screening. Specific Aim 2: To prospectively compare the clinical effectiveness of uTNE and sEGD in a population cohort. Subaim 2a: To compare the quality of esophageal assessment between sEGD, huTNE and muTNE cohorts. Quality criteria will include 1) successful esophageal intubation, 2) complete esophageal evaluation, 3) successful biopsy acquisition, 4) independent quality score by video evaluation using a validated scoring too. Subaim 2b: To compare the rates of detection of esophageal injury (esophagitis, strictures and BE) between cohorts stratified by presence/absence of GER symptoms using a validated symptom questionnaire. Specific Aim 3: To prospectively compare the short-term resource utilization and patient preferences for screening using sEGD, huTNE and muTNE in a population-based cohort. Subaim 3a: To measure the short term patient reported disutilities (patient preference associated with each test strategy) using a validated tool in the three test strategy cohorts. Subaim 3b: To compare the total short term costs (direct and indirect) and distribution of costs by type of service associated with each test strategy. The Significance that underlies the proposed research is based on the need to identify effective community- based screening strategies for BE which has the potential of improving outcomes of patients with EAC. PUBLIC HEALTH RELEVANCE: Barrett's esophagus is a precursor and strong risk factor for esophageal adenocarcinoma: a cancer with rapidly rising incidence in the United States. In this proposal we aim to identify the most acceptable and accurate way to detect Barrett's esophagus in the community by comparing regular endoscopy (performed with sedation) to unsedated transnasal endoscopy (using a thin endoscope inserted through the nose) in the community.